Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 2711-2714, May 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malden, L. T.
Right arrow Articles by Burgess, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malden, L. T.
Right arrow Articles by Burgess, A. W.

Selective Amplification of the Cytoplasmic Domain of the Epidermal Growth Factor Receptor Gene in Glioblastoma Multiforme

L. T. Malden1, U. Novak, A. H. Kaye and A. W. Burgess

Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch [L. T. M., U. N., A. W. B.], and Higginbotham Neuroscience Research Laboratory [A. H. K.], P. O. Royal Melbourne Hospital, Victoria 3050, Australia

Primary brain tumors of glial origin often overexpress epidermal growth factor receptors (EGF-Rs). This may be associated with amplification of the EGF-R gene. We have examined tissue from 23 glioblastoma multiforme tumors and found amplification and rearrangement of the EGF-R gene in four of these. The cytoplasmic domain of the EGF-R gene was invariably amplified in these four tumors, while the epidermal growth factor binding domain was not uniformly amplified in three of these tumors.

Western blot analysis of the EGF-R protein revealed high levels of a truncated EGF-R protein in two of the four tumors with EGF-R gene amplification.

1 Supported by a National Health and Medical Research Council Postgraduate Scholarship. To whom requests for reprints should be addressed.

Received 11/ 2/87. Accepted 2/15/88.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. G. Johns, T. E. Adams, J. R. Cochran, N. E Hall, P. A. Hoyne, M. J. Olsen, Y.-S. Kim, J. Rothacker, E. C. Nice, F. Walker, et al.
Identification of the Epitope for the Epidermal Growth Factor Receptor-specific Monoclonal Antibody 806 Reveals That It Preferentially Recognizes an Untethered Form of the Receptor
J. Biol. Chem., July 16, 2004; 279(29): 30375 - 30384.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. A. Jungbluth, E. Stockert, H. J. S. Huang, V. P. Collins, K. Coplan, K. Iversen, D. Kolb, T. J. Johns, A. M. Scott, W. J. Gullick, et al.
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor
PNAS, January 21, 2003; 100(2): 639 - 644.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Yang, J.-M. Yang, M. Iannone, W. J. Shih, Y. Lin, and W. N. Hait
Disruption of the EF-2 Kinase/Hsp90 Protein Complex: A Possible Mechanism to Inhibit Glioblastoma by Geldanamycin
Cancer Res., May 1, 2001; 61(10): 4010 - 4016.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. Snitkovsky, T. M. J. Niederman, B. S. Carter, R. C. Mulligan, and J. A. T. Young
A TVA-Single-Chain Antibody Fusion Protein Mediates Specific Targeting of a Subgroup A Avian Leukosis Virus Vector to Cells Expressing a Tumor-Specific Form of Epidermal Growth Factor Receptor
J. Virol., October 15, 2000; 74(20): 9540 - 9545.
[Abstract] [Full Text]


Home page
Neuro OncolHome page
L. Frederick, G. Eley, X.-Y. Wang, and C. D. James
Analysis of genomic rearrangements associated with EGFRvIII expression suggests involvement of Alu repeat elements
Neuro-oncol, July 1, 2000; 2(3): 159 - 163.
[Abstract] [PDF]


Home page
Cancer Res.Home page
L. Frederick, X.-Y. Wang, G. Eley, and C. D. James
Diversity and Frequency of Epidermal Growth Factor Receptor Mutations in Human Glioblastomas
Cancer Res., March 1, 2000; 60(5): 1383 - 1387.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. M. O'Rourke, X. Qian, H.-T. Zhang, J. G. Davis, E. Nute, J. Meinkoth, and M. I. Greene
Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains
PNAS, April 1, 1997; 94(7): 3250 - 3255.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. S. Huang, M. Nagane, C. K. Klingbeil, H. Lin, R. Nishikawa, X.-D. Ji, C.-M. Huang, G. N. Gill, H. S. Wiley, and W. K. Cavenee
The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling
J. Biol. Chem., January 31, 1997; 272(5): 2927 - 2935.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.